Leonteq Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,500
Closed -$2.26M – 1245
2024
Q2
$2.26M Buy
+2,500
New +$2M 0.16% 119

Other funds holding LLY

Leonteq Securities's LLY Position: Q3 2026 in Review

Leonteq Securities increased its Eli Lilly (LLY) stake by 161% in Q3 2026, buying an estimated $4.09M and bringing the position to 5,615 shares worth $6.5M. The position accounts for 0.27% of the portfolio, ranked #73.

Leonteq Securities first reported a position in LLY in Q4 2020 and has held it in 21 quarters since. The position peaked at $8.01M in Q1 2024. 4,216 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Leonteq Securities held 5,615 shares of Eli Lilly worth $6.5M as of Q3 2026.
  • Leonteq Securities bought 3,464 Eli Lilly shares in Q3 2026, an estimated $4.09M.
  • Eli Lilly made up 0.27% of Leonteq Securities's portfolio in Q3 2026, its #73 holding.
  • Leonteq Securities first reported a position in Eli Lilly in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities's Eli Lilly position peaked at $8.01M in Q1 2024.
  • 4,216 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.